Ned Milenkovich, PharmD, JD

Marijuana’s move to Schedule III has reignited a long-standing contradiction.

Animal pharmacy protects both farm animals and family pets through responsible medication use, compounding, and collaboration among vets, pharmacists, and owners.

Regulators should engage peptides through science-driven, pharmacy-centered oversight.

Policy Needs to Catch Up to the People Behind the Counter

Steps must be made to preserve pharmacy access for those who need it most.

A panel of 4 experts discussed the most favored nation (MFN) initiative and its impacts on research and development, market and payer distributions, and pharmacists and patients.

The bill promises lower drug costs and greater innovation, but critics still have concerns.

A novel solution can strategically control the release of the drug in vivo.

Many other issues on the new administration’s plate are taking priority.

All stakeholders should work together to determine and address drug shortages.

Some outsourcers and pharmacies have capitalized on the shortages, producing compounded versions.

Although patients hope for reduced costs, Pharma’s reaction to the IRA remains to be seen.

Pharmacists could play a major role in answering patient questions and providing counseling about cannabis

Under the proposal, specific drugs would be prohibited

Just as the pharmacy field is expanding its horizons, CE programs are offering new topics and learning strategies.

Partnering with a franchisor can provide a support system and resources for pharmacies looking to diversify revenue

The rapidly changing environment is creating new responsibilities for all staff, including technicians

Despite this decision, the trend of various states attempting to regulate pharmacy benefit managers is expected to continue

Pharmacists must carefully consider safety concerns and patient privacy.

As demand increases, pharmacies can diversify by offering brain-function assessments to patients.

Imminent March, April expiration dates indicate changes are on the horizon for pharmacy services.

November 27, 2023, marks date set by statute for full implementation of Drug Supply Chain Security Act.

Stock shelves with boutique and unique products to anchor existing customer, attract new ones.

FDA revises emergency use authorization to grant prescribing authority for Pfizer’s Paxlovid antiviral treatment for COVID-19.

New state law allows dispensation of HIV meds, distribution of fentanyl test strips starting in 2023.

Some states are pushing to increase scope of practice, expand programs.

In proposed changes, the practice would fall within nonsterile compounding.

Agency aims to allow electronic prescriptions for schedule II to V drugs between registered retail pharmacies on 1-time basis for initial fill.

State Licensing Body Begins Issuing Notices to Nonresident Pharmacies Engaged in Compounding or Dispensing Prescription Drugs for Controlled Substances

DEA seizure of large-scale narcotics points to potential drug diversion in supply chain.